Hepatoprotective effect of chewable tablet of Centella asiatica (L.) Urb extractin Wistar rats induced by high fat diets

Gotukola or Centella asiatica (L.) Urban contains high flavonoids which well known as fatty liver protector. This study aimed to evaluate the hepatoprotective effect of chewable tablet of C. asiatica (L.) Urb extract (CTCE) in Wistar rats induced by high fat diets. Twenty-one Wistar male rats aged 8-12 weeks with body weight ranging from 100-150 g were used in this study. Rats were randomly divided into seven groups i.e. Group 1 as normal control, rats were given standard food, Group 2 as high fat diets control, rats were induced high fat diets (HFD),Group 3 as positive control, rats were induced HFD and given simvastatin, Group 4 as placebo control, rats were induced HFD and given placebo, Group 5-7 as treatment group, rats were induced HFD and given CTCE at doses of 100, 200 and 300 mg/kg BW, respectively. The HFD induction was conducted for five weeks andthe CTCE was given for one week in the last week of the induction. At the end of the intervention, blood triglyceride levels and SGPT as well SGOT activities were examined. Analysis of variance (ANOVA) with confidence interval of 95% (p<0.05) was applied. The results showed that the HFD induction increased the serum triglyceride levels and SGPT activity. The serum triglyceride levels and SGPT activity of Group 2 were significantly higher than Group 1 (p<0.05). Furthermore, the simvastatin and CTCE administration reduced the serum triglyceride levels and SGPT activity. The serum triglyceride levels and SGPT activity of Group 3, 5, 6and 7 were significantly lower than Group 2 and 4 (p<0.05). In addition, the serum triglyceride levels and SGPT activity of Group 5, 6 and 7 were significantly lower than Group 3 (p<0.05). In conclusion, CTCE can reduce the serum triglyceride levels and SGPT activity in Wistar rats induced by HFD.

[1]  S. Ima-Nirwana,et al.  Regulation of inflammatory response and oxidative stress by tocotrienol in a rat model of non-alcoholic fatty liver disease , 2020 .

[2]  M. Yeh,et al.  Non-alcoholic fatty liver disease: A review with clinical and pathological correlation. , 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

[3]  N. Chavez-Tapia,et al.  Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease. , 2020, Annals of hepatology.

[4]  Xiaohui Li,et al.  Asiaticoside nitric oxide gel accelerates diabetic cutaneous ulcers healing by activating Wnt/β-catenin signaling pathway. , 2019, International immunopharmacology.

[5]  Daqing Zhao,et al.  Protective effect of Hedansanqi Tiaozhi Tang against non-alcoholic fatty liver disease in vitro and in vivo through activating Nrf2/HO-1 antioxidant signaling pathway. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[6]  B. Nkambule,et al.  Obesity-induced inflammation and insulin resistance: A mini-review on T-cells , 2019, Metabolism open.

[7]  S. Louala,et al.  Low carbohydrate caloric restriction diet prevents non alcoholic fatty liver disease development, improves pro/antioxidant status and nitric oxide bioavailability in obese rat , 2019, Archives of Cardiovascular Diseases Supplements.

[8]  V. Wong,et al.  Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. , 2019, The lancet. Gastroenterology & hepatology.

[9]  Z. Younossi.  Non-alcoholic fatty liver disease - A global public health perspective. , 2019, Journal of hepatology.

[10]  S. Bozinovski,et al.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies , 2019, Pharmacology & Therapeutics.

[11]  F. Tacke,et al.  Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism , 2019, JHEP reports : innovation in hepatology.

[12]  Chandragouda R. Patil,et al.  Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise , 2018, Front. Pharmacol..

[13]  D. Bernstein,et al.  Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics. , 2018, Clinics in liver disease.

[14]  Vincent Wai-Sun Wong,et al.  New trends on obesity and NAFLD in Asia. , 2017, Journal of hepatology.

[15]  S. Prasad,et al.  Phytochemical and pharmacological evaluation of organic and non-organic cultivated nutritional Centella asiatica collected after different time intervals of harvesting , 2017 .

[16]  A. Alexander-Aguilera,et al.  Effect of Litchi chinensis on adipose and hepatic tissues in rats with obesity and non-alcoholic fatty liver disease (NAFLD) , 2017, Journal of the Saudi Society of Agricultural Sciences.

[17]  A. Bast,et al.  The potential of flavonoids in the treatment of non-alcoholic fatty liver disease , 2017, Critical reviews in food science and nutrition.

[18]  S. Sutardi.  Kandungan Bahan Aktif Tanaman Pegagan dan Khasiatnya untuk Meningkatkan Sistem Imun Tubuh , 2017 .

[19]  Mochamad Akrom,et al.  Tablet kunyah ekstrak etanol herba pegagan (Centella asiatica (L.), Urban) menurunkan kadar kreatinin tikus putih jantan (Rattus norvegicus L.) galur wistar yang diberi diet lemak tinggi , 2016 .

[20]  Z. Goodman,et al.  Epidemiology and natural history of non-alcoholic fatty liver disease. , 2016, Metabolism: clinical and experimental.

[21]  Lalita Subedi,et al.  Antioxidant activity and phenol and flavonoid contents of eight medicinal plants from Western Nepal. , 2014, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[22]  N. C. Gonzaga,et al.  Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents. , 2013, Jornal de pediatria.

[23]  Suriyavathana Muthukrishnan,et al.  Effect of Nigella sativa seed extract on carbon tetrachloride-induced hepatotoxicity in rats , 2012 .

[24]  N. Ismail,et al.  Frequency of non-alcoholic fatty liver disease in overweight/obese children and adults: Clinical, sonographic picture and biochemical assessment , 2012 .

[25]  W. Peres,et al.  Association between non-alcoholic fatty liver disease and liver function/injury markers with metabolic syndrome components in class III obese individuals. , 2012, Revista da Associacao Medica Brasileira.

[26]  Faiza Maryani,et al.  Antioxidant and α-Glucosidase Inhibitory Compounds of Centella Asiatica , 2015 .